Nath Bio-Genes (India) Ltd share price logo

Nath Bio-Genes (India) Ltd

NSE: NATHBIOGEN

BSE: 537291

Small Cap

FMCG Sector

Retail Sector

₹161.39

+1.43

(+0.89%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Nath Bio-Genes (India) Stock Performance

as on July 30, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹160.40
    ₹169.90
    downward going graph

    0.61%

    Downside

    5.27%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹126.15
    ₹204.00
    downward going graph

    21.84%

    Downside

    26.40%

    Upside

    downward going graph

Nath Bio-Genes (India) share price movements today

Previous Close
₹159.96
Open
₹162.20
Volume
94.95K
Upper Circuit
₹191.95
Lower Circuit
₹127.97
Day's Low - High
₹160.40 - ₹169.90
52 Week Low - High
₹126.15 - ₹204.00

Nath Bio-Genes (India) Historical Returns

1 Month Return
-2.92 %
3 Month Return
-18.39 %
1 Year Return
-12.04 %
3 Year Return
-23.21 %
5 Year Return
-56.26 %

Nath Bio-Genes (India) Fundamentals

as on July 30, 2026 at 4:01 pm IST

Market Cap

₹303.99 Cr

Return on Equity (ROE)

6.69

PE Ratio (TTM)

8.16

Return on capital employed (ROCE)

7.25

Industry PE ratio

47.5

Beta (LTM)

0.9

P/B Ratio

0.43

Dividend Yield

1.37

PEG Ratio

3.33

Quarterly Earnings Growth YOY

14.07

EPS (TTM)

20.31

Book Value

339.08

Nath Bio-Genes (India) Stock Valuation

as on July 30, 2026 at 4:01 pm IST

Nath Bio-Genes (India) in the last 5 years

  • Overview

  • Trends

Lowest (-3.78x)

January 3, 2023

Today (8.16x)

July 29, 2026

Industry (47.50x)

July 29, 2026

Highest (13.69x)

July 9, 2025

LowHigh

Today’s Price to Earnings Ratio: 8.16x

Nath Bio-Genes (India) Technical Analysis

Track how Nath Bio-Genes (India) technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish13
Bullish1
Neutral1

Oscillators

Name

Value

Action

MACD level (12,26)
-0.05
Bearish
CCI (20)
526.1
Bearish
RSI (14)
45.54
Neutral
Momentum (10)
-0.35
Bullish
ADI (14)
25.26
Bearish
Ultimate Oscillator (7,14,28)
15.27
Bearish

Moving Averages

Name

Value

Action

SMA (20)
161.66
Bearish
EMA (20)
161.62
Bearish
VWMA (20)
161.6
Bearish
SMA (50)
161.69
Bearish
EMA (50)
161.72
Bearish
SMA (200)
162.24
Bearish
EMA (200)
162.19
Bearish
KAMA (200)
161.72
Bearish
DEMA (200)
161.69
Bearish

Nath Bio-Genes (India) Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Nath Bio-Genes (India) with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Nath Bio-Genes (India) Ltd image
Nath Bio-Genes (India) Ltd
NA303.99-11.25%0.5838364
Prataap Snacks Ltd image
Prataap Snacks Ltd
BUY2,693.7610.91%0.00201,652
Sonalis Consumer Products Ltd image
Sonalis Consumer Products Ltd
NA23.685%0.002106
Elfin Agro India Ltd image
Elfin Agro India Ltd
NA160.8214.79%0.005145
Dodla Dairy Ltd image
Dodla Dairy Ltd
BUY6,397.1614.33%0.522674,125
See all

Nath Bio-Genes (India) Stock’s Investor Sentiment and Interest

Search interest for Nath Bio-Genes (India) Ltd Stock has decreased by -9% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-9% versus previous 30 day period

Nath Bio-Genes (India) Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
22.57
31.74
43.04
243.88
32.19
36.87
51.97
283.7
43.85
65.96
51.59
328.4
Other Income
0.06
2.54
1.36
0.13
0.08
0.48
4.4
3.83
4
4.42
3.63
3.1
Total Income
22.63
34.27
44.4
244.01
32.27
37.35
56.37
287.53
47.85
70.38
55.23
331.5
Expenses
17.59
26.09
39.11
207.34
27.38
28.84
51.55
254.42
37.75
62.39
47.12
293.25
Operating Profit
4.98
5.65
3.93
36.54
4.81
8.03
0.42
29.28
6.1
3.57
4.47
35.15
Operating Profit Margin %
22.06%
17.8%
9.13%
14.98%
14.94%
21.78%
0.81%
10.32%
13.91%
5.41%
8.66%
10.7%
Profit Before Interest, Tax and Depreciation
5.04
8.18
5.29
36.67
4.89
8.51
4.82
33.11
10.1
8
8.11
38.25
Interest
2.44
2.84
1.07
2.24
2.98
3.9
1.37
3.2
3.66
4.54
4.59
4.26
Depreciation
0.76
0.76
0.98
0.83
0.83
0.83
1.34
0.98
0.99
0.98
1.03
1.01
Profit Before Tax
1.84
4.58
3.24
33.6
1.08
3.78
2.11
28.93
5.45
2.48
2.49
32.98
Tax Paid
0.35
0.77
0.62
0.25
-0.03
1.14
0.63
0.66
0.64
0.87
2.5
0.72
Profit After Tax
1.5
3.82
2.62
33.35
1.11
2.65
1.48
28.28
4.82
1.6
-0.01
32.26
Total Net profit including share of profit / Loss from associate company
1.5
3.82
2.62
33.35
1.11
2.65
1.48
28.28
4.82
1.6
-0.01
32.26
EPS
0.86
2.02
1.87
17.49
0.53
1.33
0.42
14.88
2.53
0.89
-0.79
16.98
Actual EPS
0.86
2.02
1.87
17.49
0.53
1.33
0.42
14.88
2.53
0.89
-0.79
16.98
Adjusted EPS
0.86
2.02
1.87
17.49
0.53
1.33
0.42
14.88
2.53
0.89
-0.79
16.98
Diluted EPS
0.86
2.02
1.87
17.49
0.53
1.33
0.42
14.88
2.53
0.89
-0.79
16.98

Nath Bio-Genes (India) Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
278.36
301.36
332.62
364.91
445.1
Other Income
1.85
0.55
4.08
5.09
13.82
Total Income
280.22
301.92
336.7
369.99
458.92
Expenses
329.96
252.62
282.76
315.11
392.66
Operating Profit
-51.6
48.74
49.86
49.8
52.44
Operating Profit Margin %
-18.54%
16.17%
14.99%
13.65%
11.78%
Profit Before Interest, Tax and Depreciation
-49.74
49.3
53.94
54.88
66.26
Interest
10.61
10.12
9.11
10.48
15.99
Depreciation
3.08
3.01
3.26
3.82
3.96
Profit Before Tax
-63.43
36.17
41.57
40.58
46.31
Tax Paid
3.95
1.15
1.95
1.98
4.67
Profit After Tax
-67.39
35.01
39.62
38.6
41.63
Total Net profit including share of profit / Loss from associate company
-67.39
35.01
39.62
38.6
41.63
EPS
-35.46
18.44
21.34
20.14
20.98
Actual EPS
-35.46
18.44
21.34
20.14
20.98
Adjusted EPS
-35.46
18.44
21.34
20.14
20.98
Diluted EPS
-35.46
18.44
21.34
20.14
20.98

Nath Bio-Genes (India) Ltd Cash Flow

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
17.05
38.37
74.59
17.58
Cash Flow from Investing Activities
-19.86
-2.88
-27.41
-3.96
Cash Flow from Financing Activities
-22.23
-1.66
-7.78
-2.12
Net Cash Flow
-25.04
33.81
39.41
11.49

Nath Bio-Genes (India) Stock Shareholding Pattern

Numbers in percentages

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
45.6%
45.6%
45.6%
45.6%
45.6%
45.6%
45.6%
45.6%
45.6%
45.6%
45.6%
45.6%
DII
4.37%
4.37%
4.37%
4.38%
4.37%
4.37%
3.94%
2.25%
0.76%
0.01%
0.01%
0.01%
FII
0.22%
0%
0.27%
0.22%
0.19%
0.19%
0.21%
0.42%
0.32%
0.31%
0.23%
0.27%
Public
49.81%
49.72%
49.76%
49.81%
49.85%
49.84%
50.25%
51.74%
53.32%
54.08%
54.17%
54.13%
Total Outstanding Shares
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
1,90,04,000
Total Shareholders
34,365
34,263
35,132
35,834
35,423
35,056
34,911
34,207
34,122
33,550
33,031
32,564

Nath Bio-Genes (India) Corporate Actions

View detailed summary of the earnings and dividend history of Nath Bio-Genes (India).

  • Nath Bio-Genes (India) Ltd Earnings Results

    Nath Bio-Genes (India) Ltd’s net profit jumped 14.07% since last year same period to ₹32.26Cr in the Q1 2026-2027. On a quarterly growth basis, Nath Bio-Genes (India) Ltd has generated 322700% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Nath Bio-Genes (India) Ltd Dividends April,2025

    In the quarter ending March 2025, Nath Bio-Genes (India) Ltd has declared dividend of ₹2.00 per share on 29 Apr 2025 - translating a dividend yield of 2.50%.

    Read More about Dividends

Insights on Nath Bio-Genes (India) Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, NATHBIOGEN stock has moved up by 3.4%

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.23% to 0.27% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -0.01 Cr → 32.26 Cr (in ₹), with an average increase of 100.0% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 55.23 Cr → 331.5 Cr (in ₹), with an average increase of 83.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Avanti Feeds Ltd has given 132.1% return, outperforming this stock by 155.3%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 45.60% of holdings in Jun 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Avanti Feeds Ltd has given 36.9% return, outperforming this stock by 49.0%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 54.17% to 54.13% in Jun 2026 quarter

About Nath Bio-Genes (India) Ltd

Nath BioGenes India Limited was established in 1993, as a private limited company, to produce, process and market hybrid and GM seeds. With 16 business centers spanning 131 territories across India, it has an extensive network of 2000 distributors, enabling it to cater to PAN India and far abroad markets in Asia, Africa and the Middle East. To improve the quality of its production, the company has incorporated modern infrastructure facilities, biotech and seed technology labs. Their range of field crop, vegetable crop and plant nutrient supplements have enabled it to gain various prestigious awards, such as the Vasantrao Naik Prathisthan Award, for its contribution towards enhancing agricultural productivity. It has also collaborated with major International and National Centres of Excellence, such as the NRCPB, CIMMYT, IRRI, and ICRISAT. The company has set rigorous field standards, quality control checks, and elaborate seed processing facilities, to ensure that only seeds of the highest quality reaches customers. Its 3-phase trial system with 40 testing locations, 8 centres, and all agroclimatic zones of India, has enabled it to rigorously test products and compare yields with competitor products. This comprehensive system has allowed Nath BioGenes India Limited to be a successful hybrid and GM seed provider in India and internationally.

Revenue: ₹328.40Cr as on June 2026 (Q1 FY27)
Net Profit: ₹32.26Cr as on June 2026 (Q1 FY27)
Listing date: 28 Jan, 2014
OrganisationNath Bio-Genes (India) Ltd
IndustryFMCG
E-voting on sharesClick here to vote

FAQs

What is Nath Bio-Genes (India) share price today?

Nath Bio-Genes (India) share price today stands at ₹161.39 as on at the close of the market. Nath Bio-Genes (India) share today touched a day high of ₹169.9 and a low of ₹160.4.

What is the 52 week high and 52 week low range for Nath Bio-Genes (India) share?

Nath Bio-Genes (India) touched a 52 week high of ₹204 and a 52 week low of ₹126.15. Nath Bio-Genes (India) share price today i.e. is closed at ₹161.39, which is -20.89% down from its 52 week high and 27.93% up from its 52 week low.

What is Nath Bio-Genes (India)'s market capitalisation today?

Nath Bio-Genes (India) market capitalisation is ₹303.99 Cr as on .

How to buy Nath Bio-Genes (India) shares?

To buy Nath Bio-Genes (India) shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for NATHBIOGEN or Nath Bio-Genes (India) Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Nath Bio-Genes (India) shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Nath Bio-Genes (India) trading volume today?

Nath Bio-Genes (India) trading volume is 94.95K as on . This means that 94.95K shares of Nath Bio-Genes (India) were bought and sold on the stock market during today's trading session.